Latent Abnormal Pathology Affects Long-Term Graft Function in Elder Living Renal Allograft Recipients

Table 5

Long-term graft function in various arteriolopathy and microangiopathy compared with and without pathological changes.

Path. change

𝑛

Average age*

Serum Cr (umol/L)^#

BUN (mmol/L)^§

Uric acid (mmol/L)^△

D

R

3 (m)

6

12

24

3 (m)

6

12

24

3 (m)

6

12

24

Normal

37

37±8

35±13

112±18

106±17

124.7±19.8

113±9.3

6.6±1.4

6.4±2.6

6.4±3

6.4±2.1

320±46

329±33

345±37

344±30

Arteriolopathy I

9

46±6

33±9

119±16

111±9.8

113.5±14.9

196±268

7.1±1.4

7.3±1

7.2±1.3

9.6±6.2

360±88

310±77

329±70

358±91

Arteriolopathy II

6

53±8

33±9

113±29

108±21

112.3±13.5

227±192

6.1±1.8

6.1±0.7

6.5±1.9

10±4.4

310±77

335±106

282±31

379±126

Glomerulosclerosis

4^&

54±3

31±10

103±17

98±19

103±13

270±333

5.0±1.1

6.9±1.8

8.0±1

10.9±7.8

272±43

321±81

317±72

336±67

Compared with normal: *age, 𝑃<0.05; ^#serum Cr at 24 months, 𝑃<0.05; §BUN at 24 months, 𝑃<0.05; ^△uric acid at 24 months, 𝑃>0.05; ^&three cases of complicated arteriolopathy were observed.